The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project

  • Sargent D
  • Shi Q
  • et al.
8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.

Cite

CITATION STYLE

APA

Sargent, D. J., Shi, Q., Flowers, C. R., Schmitz, N., Habermann, T. M., … Coiffier, B. (2017). The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project. The Oncologist, 22(12), 1415–1418. https://doi.org/10.1634/theoncologist.2017-0177

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free